
Frankie L. Stinson
Examiner (ID: 8117)
| Most Active Art Unit | 1746 |
| Art Unit(s) | 1792, 1711, 2402, 1746, 2899, 3405, 1743 |
| Total Applications | 3621 |
| Issued Applications | 3013 |
| Pending Applications | 138 |
| Abandoned Applications | 470 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12546180
[patent_doc_number] => 10011600
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-03
[patent_title] => Methods and compositions for inhibition of Ras
[patent_app_type] => utility
[patent_app_number] => 15/508387
[patent_app_country] => US
[patent_app_date] => 2015-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 28699
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 442
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508387
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/508387 | Methods and compositions for inhibition of Ras | Sep 24, 2015 | Issued |
Array
(
[id] => 11971143
[patent_doc_number] => 20170275297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'INHIBITORS OF IRAK4 ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/515383
[patent_app_country] => US
[patent_app_date] => 2015-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20369
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15515383
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/515383 | Inhibitors of IRAK4 activity | Sep 24, 2015 | Issued |
Array
(
[id] => 11836261
[patent_doc_number] => 20170217981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'INHIBITORS OF IRAK4 ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/515377
[patent_app_country] => US
[patent_app_date] => 2015-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17923
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15515377
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/515377 | Inhibitors of IRAK4 activity | Sep 24, 2015 | Issued |
Array
(
[id] => 12565866
[patent_doc_number] => 10017529
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-10
[patent_title] => Metformin derivatives
[patent_app_type] => utility
[patent_app_number] => 15/511902
[patent_app_country] => US
[patent_app_date] => 2015-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11863
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15511902
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/511902 | Metformin derivatives | Sep 15, 2015 | Issued |
Array
(
[id] => 10654638
[patent_doc_number] => 20160000781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'PHTHALAZINONE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/853360
[patent_app_country] => US
[patent_app_date] => 2015-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20649
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14853360
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/853360 | Phthalazinone derivatives | Sep 13, 2015 | Issued |
Array
(
[id] => 11963480
[patent_doc_number] => 20170267634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'COMPOUNDS AS CRTH2 ANTAGONIST AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/504018
[patent_app_country] => US
[patent_app_date] => 2015-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 63035
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15504018
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/504018 | Compounds as CRTH2 antagonist and uses thereof | Sep 10, 2015 | Issued |
Array
(
[id] => 10489641
[patent_doc_number] => 20150374661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'BIOLOGICALLY ACTIVE MACROLIDES, COMPOSITIONS, AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/849798
[patent_app_country] => US
[patent_app_date] => 2015-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 26415
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14849798
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/849798 | Biologically active macrolides, compositions, and uses thereof | Sep 9, 2015 | Issued |
Array
(
[id] => 11949441
[patent_doc_number] => 20170253591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'HETEROCYCLIC COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 15/510225
[patent_app_country] => US
[patent_app_date] => 2015-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 96597
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510225
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/510225 | Heterocyclic compound | Sep 9, 2015 | Issued |
Array
(
[id] => 13702525
[patent_doc_number] => 20170362217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => Substituted Piperidine Compounds
[patent_app_type] => utility
[patent_app_number] => 15/510588
[patent_app_country] => US
[patent_app_date] => 2015-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -78
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510588
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/510588 | Substituted piperidine compounds | Sep 8, 2015 | Issued |
Array
(
[id] => 13079241
[patent_doc_number] => 10059678
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-28
[patent_title] => Process for preparing olodaterol and intermediates thereof
[patent_app_type] => utility
[patent_app_number] => 15/510147
[patent_app_country] => US
[patent_app_date] => 2015-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3713
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510147
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/510147 | Process for preparing olodaterol and intermediates thereof | Sep 8, 2015 | Issued |
Array
(
[id] => 13013791
[patent_doc_number] => 10030003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-24
[patent_title] => Synthesis of isoflavanes and intermediates thereof
[patent_app_type] => utility
[patent_app_number] => 15/507371
[patent_app_country] => US
[patent_app_date] => 2015-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11641
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15507371
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/507371 | Synthesis of isoflavanes and intermediates thereof | Sep 8, 2015 | Issued |
Array
(
[id] => 10712616
[patent_doc_number] => 20160058763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-03
[patent_title] => 'NOVEL HETEROCYCLIC CARBOXAMIDES AS MODULATORS OF KINASE ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/847561
[patent_app_country] => US
[patent_app_date] => 2015-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24964
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14847561
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/847561 | NOVEL HETEROCYCLIC CARBOXAMIDES AS MODULATORS OF KINASE ACTIVITY | Sep 7, 2015 | Abandoned |
Array
(
[id] => 10491114
[patent_doc_number] => 20150376133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'C-Met Modulators and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 14/847801
[patent_app_country] => US
[patent_app_date] => 2015-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83122
[patent_no_of_claims] => 168
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14847801
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/847801 | C-Met Modulators and Methods of Use | Sep 7, 2015 | Abandoned |
Array
(
[id] => 10489674
[patent_doc_number] => 20150374695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => '6-PIPERAZINYL-3,4-DIHYDROQUINAZOLIN-2(1H)-ONES'
[patent_app_type] => utility
[patent_app_number] => 14/848058
[patent_app_country] => US
[patent_app_date] => 2015-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6952
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14848058
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/848058 | 6-Piperazinyl-3,4-dihydroquinazolin-2(1H)-ones | Sep 7, 2015 | Issued |
Array
(
[id] => 10169267
[patent_doc_number] => 09199969
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-12-01
[patent_title] => '6-piperazinyl-3,4-dihydroquinazolin-2(1H)-ones'
[patent_app_type] => utility
[patent_app_number] => 14/848008
[patent_app_country] => US
[patent_app_date] => 2015-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 6952
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14848008
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/848008 | 6-piperazinyl-3,4-dihydroquinazolin-2(1H)-ones | Sep 7, 2015 | Issued |
Array
(
[id] => 11357364
[patent_doc_number] => 09534006
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-03
[patent_title] => 'Organometallic complex, light-emitting element, light-emitting device, electronic device, and lighting device'
[patent_app_type] => utility
[patent_app_number] => 14/846181
[patent_app_country] => US
[patent_app_date] => 2015-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 73
[patent_no_of_words] => 41655
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14846181
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/846181 | Organometallic complex, light-emitting element, light-emitting device, electronic device, and lighting device | Sep 3, 2015 | Issued |
Array
(
[id] => 10491121
[patent_doc_number] => 20150376141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'NEW COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/845529
[patent_app_country] => US
[patent_app_date] => 2015-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19583
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14845529
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/845529 | NEW COMPOUNDS | Sep 3, 2015 | Abandoned |
Array
(
[id] => 16246054
[patent_doc_number] => 10745395
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-18
[patent_title] => Compounds for their use as drugs for the treatment and/or the prevention of infection(s) caused by biofilm-forming bacteria
[patent_app_type] => utility
[patent_app_number] => 15/507028
[patent_app_country] => US
[patent_app_date] => 2015-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 10
[patent_no_of_words] => 32209
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15507028
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/507028 | Compounds for their use as drugs for the treatment and/or the prevention of infection(s) caused by biofilm-forming bacteria | Aug 25, 2015 | Issued |
Array
(
[id] => 11936415
[patent_doc_number] => 20170240566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'AMINO-SUBSTITUTED ANNULATED PYRIMIDINES AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/503578
[patent_app_country] => US
[patent_app_date] => 2015-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26044
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503578
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/503578 | AMINO-SUBSTITUTED ANNULATED PYRIMIDINES AND USE THEREOF | Aug 24, 2015 | Abandoned |
Array
(
[id] => 11936437
[patent_doc_number] => 20170240588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'AMPHIPHILIC COMPOUNDS WITH NEUROPROTECTIVE PROPERTIES'
[patent_app_type] => utility
[patent_app_number] => 15/506318
[patent_app_country] => US
[patent_app_date] => 2015-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48791
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15506318
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/506318 | Amphiphilic compounds with neuroprotective properties | Aug 24, 2015 | Issued |